News

Malted milk drinks, which are as much as one-third sugar, have been breakfast staples of upwardly mobile families in India since soldiers brought GlaxoSmithKline's Horlicks back with them after WW1   For a century, children in India have been brought up on malt-flavored powdered milk drinks that they thought would help make them healthy and strong. Now the $1 billion industry is set for a shake-up after two of the biggest producers, GlaxoSmithKline Plc and Kraft Heinz Co. put the businesses up for sale and consumers switch to drinks with less sugar. Malted milk drinks, which are as much as one-third sugar, have been breakfast staples of upwardly mobile families in India since soldiers brought GlaxoSmithKline’s  Horlicks  back with them after the First World War. Now, after a decade of double-digit growth, sales in India rose 8.6 per cent in 2017 and could drop to half that this year. By 2022, the market will expand by only 2.7 per cent, Euromonitor forecasts...

GlaxoSmithKline and Alphabet create $715 mln bioelectronics firm GlaxoSmithKline and Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a new field of medicine known as bioelectronics. Verily Life Sciences   — known as Google's life sciences unit until last year — and Britain's biggest drugmaker will together contribute £540 million ($715.12 million) over seven years to Galvani Bioelectronics, they said on Monday. The new company will be based at GSK's Stevenage research centre north of London, with a second research hub in South San Francisco. GSK   first unveiled its ambitions in   bioelectronics   in a paper in the journal Nature three years ago and believes it is ahead of   Big Pharma   rivals in developing medicines that use electrical impulses rather than traditional chemicals or proteins. For Verily, the tie-up is the latest sign that Google's ...